LMT-28
Anti-IL-6 / IFNb2 (MEDI 5117)
Sirukumab (Anti-IL-6 / IFNb2)
Ziltivekimab (Anti-IL-6 / IFNb2)
Sapelizumab (Anti-IL-6Ra / CD126)
Levilimab (Anti-IL-6Ra / CD126)
Ixekizumab (Anti-CTLA-8 / IL-17a)
Netakimab (Anti-CTLA-8 / IL-17a)
Perakizumab (Anti-CTLA-8 / IL-17a)
Vunakizumab (Anti-CTLA-8 / IL-17a)
Gevokizumab (Anti-IL-1b)
Cendakimab (Anti-IL-13)
Dectrekumab (Anti-IL-13)
Anti-IL-13 (IMA-026)
Melrilimab (Anti-IL-1RL1 / ST2 / IL-33R)
Lebrikizumab (Anti-IL-13)
Avizakimab (Anti-IL-21)
Brazikumab (Anti-IL-23)
Camidanlumab (Anti-IL-2Ra / CD25)
Anti-IL-23 (LY2525623)